glp 1 npo guidelines How should GLP-1 receptor agonists be managed in the perioperative period? GLP-1 receptor agonists review and

doi: 10.3390/jcm13216292

While these medications can offer powerful benefits, they do not replace the essential roles of a healthy diet and regular exercise

Key genetic variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313) predict which patients achieve optimal weight loss with standard dosing versus those requiring higher doses or different compounds

In clinical trials, participants using Zepbound achieved an average weight loss of approximately 20.2% over 72 weeks, while those on Wegovy experienced about a 13.7% reduction

Lets look at what the science actually shows

License No